In one paragraphArticle in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
15 authors.
Samrat DasEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-7672-3374 Shefali ThakurEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-8252-8671 Vincent CahaisEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0001-5530-4368 François VirardEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0001-7570-1088 Liesel ClaeysEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0001-9566-1861 Claire RenardEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0001-6523-3962 Cyrille CueninEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.
Marie-Pierre CrosEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.
Stéphane KeïtaEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.
Assunta VenutiEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0001-5438-1724 Cécilia SirandEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.
Akram GhantousEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-2582-6402 Zdenko HercegEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-4109-3154 Michael KorenjakEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-3242-7968 Jiri ZavadilEpigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-0640-5562 Funding
Modeling mutational landscapes of primary cancers using an in vitro cell immortalization assayR03ES025023 · NIEHS · INTERNATIONAL AGENCY FOR RES ON CANCER · PI OLIVIER, MAGALI · 2015 to 2016
$113kNIEHS NIH HHS R03 ES025023
6 · The paper itselfAbstract
Chronic arsenic exposure can lead to various health issues, including cancer. Concerns have been mounting about the enhancement of arsenic toxicity through co-exposure to various prevalent lifestyle habits. Smokeless tobacco products are commonly consumed in South Asian countries, where their use frequently co-occurs with exposure to arsenic from contaminated groundwater. To decipher the
Indexed as
apoptosisarsenicDNA methylationgene expressioninflammatory responselive cell analysisoral cellssmokeless tobaccowhole-exome sequencing
Identifiers
PMID39463997
PMCPMC11507705
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390